Total Payments
$6,877
2024 Payments
$1,066
Companies
43
Transactions
347
Medicare Patients
3,411
Medicare Billing
$350,167
Payment Breakdown by Category
Food & Beverage$6,877 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,877 | 347 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $1,093 | 73 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $864.25 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $791.41 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $779.99 | 28 | $0 (2024) |
| GENZYME CORPORATION | $419.38 | 15 | $0 (2024) |
| PFIZER INC. | $304.27 | 25 | $0 (2024) |
| Shire North American Group Inc | $183.26 | 14 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $174.03 | 3 | $0 (2022) |
| Genentech USA, Inc. | $160.87 | 11 | $0 (2021) |
| Daiichi Sankyo Inc. | $150.49 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,066 | 54 | Regeneron Healthcare Solutions, Inc. ($214.88) |
| 2023 | $1,007 | 59 | AstraZeneca Pharmaceuticals LP ($307.89) |
| 2022 | $1,278 | 58 | OptiNose US, Inc. ($259.78) |
| 2021 | $834.95 | 50 | Optinose US, Inc. ($206.54) |
| 2020 | $683.22 | 37 | GlaxoSmithKline, LLC. ($143.62) |
| 2019 | $877.25 | 32 | OptiNose US, Inc. ($231.46) |
| 2018 | $471.17 | 26 | Bio Products Laboratory USA, Inc. ($85.03) |
| 2017 | $660.10 | 31 | NOVADAQ TECHNOLOGIES INC. ($139.72) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/11/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $118.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $44.94 | General |
| Category: Immunology | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/19/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Neurent Medical Limited | NEUROMARK Device (Device), NEUROMARK Radiofrequency Console | Food and Beverage | Cash or cash equivalent | $22.04 | General |
| Category: Electrosurgical, Cutting & Coagulation & Accessories | ||||||
| 10/15/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/15/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: PAIN | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | WATERMARK MEDICAL, INC. | ARES 620 UNICORDER (Device) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: VENTILATORY EFFORT RECORDER | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | WATERMARK MEDICAL, INC. | ARES 620 UNICORDER (Device) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: VENTILATORY EFFORT RECORDER | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: IMMUNOLOGY | ||||||
| 06/19/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: PAIN | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 753 | 926 | $254,185 | $84,784 |
| 2022 | 15 | 1,118 | 2,136 | $337,606 | $110,220 |
| 2021 | 10 | 847 | 959 | $263,595 | $91,434 |
| 2020 | 9 | 693 | 763 | $190,390 | $63,729 |
Total Patients
3,411
Total Services
4,784
Medicare Billing
$350,167
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 214 | 320 | $48,595 | $21,713 | 44.7% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 111 | 123 | $62,001 | $17,293 | 27.9% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2023 | 89 | 106 | $63,313 | $16,448 | 26.0% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 73 | 103 | $28,862 | $9,363 | 32.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 97 | 97 | $21,774 | $8,464 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 41 | $8,200 | $4,113 | 50.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $6,910 | $3,100 | 44.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 40 | 41 | $5,125 | $1,728 | 33.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 32 | 39 | $4,680 | $1,047 | 22.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $2,925 | $979.99 | 33.5% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 15 | 15 | $1,800 | $535.49 | 29.7% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2022 | 122 | 151 | $90,600 | $23,745 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 223 | 303 | $45,450 | $21,671 | 47.7% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 133 | 154 | $77,000 | $21,260 | 27.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 148 | 148 | $33,300 | $12,623 | 37.9% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 73 | 95 | $26,125 | $9,317 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 40 | $8,000 | $4,114 | 51.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 65 | 77 | $9,625 | $3,304 | 34.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 56 | 56 | $8,400 | $2,903 | 34.6% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 62 | 86 | $10,320 | $2,717 | 26.3% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 12 | 395 | $5,135 | $2,605 | 50.7% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 53 | 56 | $6,720 | $1,937 | 28.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 12 | 456 | $6,156 | $1,562 | 25.4% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 50 | 50 | $4,400 | $1,472 | 33.4% |
| 92567 | Test to assess middle ear function | Office | 2022 | 49 | 49 | $3,675 | $641.40 | 17.5% |
About Dr. Amit Patel, MD
Dr. Amit Patel, MD is a Otolaryngology healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1598076184.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Patel, MD has received a total of $6,877 in payments from pharmaceutical and medical device companies, with $1,066 received in 2024. These payments were reported across 347 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,877).
As a Medicare-enrolled provider, Patel has provided services to 3,411 Medicare beneficiaries, totaling 4,784 services with total Medicare billing of $350,167. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngology, Otolaryngology
- Location Warwick, RI
- Active Since 06/29/2010
- Last Updated 10/23/2025
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1598076184
Products in Payments
- DUPIXENT (Biological) $1,226
- Xhance (Drug) $1,093
- NUCALA (Biological) $666.04
- NURTEC ODT (Drug) $343.49
- FASENRA (Biological) $264.34
- BREZTRI (Drug) $184.14
- AIRSUPRA (Drug) $146.93
- SPY Technology (Device) $139.72
- TEZSPIRE (Biological) $139.13
- CUVITRU (Biological) $138.97
- ENHERTU (Drug) $136.74
- Odactra (Drug) $132.63
- TRELEGY ELLIPTA (Drug) $125.37
- Gammaplex (Drug) $118.54
- Gammaplex 10% (Biological) $114.70
- UBRELVY (Drug) $103.75
- TEFLARO (Drug) $99.35
- TECENTRIQ (Biological) $90.03
- XPRESS ENT DILATION SYSTEM (Device) $79.63
- AUVI-Q (Drug) $78.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Warwick
Dr. Mark Andreozzi, D.o, D.O
Otolaryngology — Payments: $18,261
Otolaryngology $18,261
Dr. Alejandro Vazquez, Md, MD
Otolaryngology — Payments: $13,866
Otolaryngology $13,866
Dr. Barbara Guillette, M.d, M.D
Otolaryngology — Payments: $6,372
Otolaryngology $6,372
George Jacewicz, M.d, M.D
Otolaryngology
Otolaryngology